Author

I. B. Passos

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Organism:mouse· 2 Research Focus:drug response / drug discovery· 1 Assay:proteomics· 1

Frequent Co-Authors

C. M. Queiroz-Junior· 2 shared M. M. Teixeira· 2 shared A. C. d. S. P. Andrade· 1 shared A. C. Ferreira· 1 shared A. Cramer· 1 shared A. F. A. Figueiredo· 1 shared B. R. Barrioni· 1 shared C. A. Oliveira· 1 shared

Activity by Year

2021-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 38 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

C. M. Queiroz-Junior

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting the Annexin A1-FPR2/ALX pathway for host-directed therapy in dengue disease

V. V. Costa, M. A. Sugimoto, J. Hubner, C. S. Bonilha, C. M. Queiroz-Junior, M. H. Goncalves-Pereira, J. Chen, T. Gobbetti, G. O. Libanio Rodrigues, J. L. Bambirra, I. B. Passos, C. E. Machado Lopes, T. P. Moreira, K. Bonjour, R. C. N. Melo, , M. M. Teixeira

This study identifies reduced Annexin A1 levels in dengue patients and mice, showing that AnxA1 agonists reduce disease severity by modulating mast cell degranulation.

bioRxiv · Nov 2, 2021Microbiology

A suitable murine model for studying respiratory coronavirus infection and therapeutic countermeasures in BSL-2 laboratories

A. C. d. S. P. Andrade, G. H. Campolina-Silva, C. M. Queiroz-Junior, L. C. de Oliveira, L. d. S. B. Lacerda, J. C. Pimenta, F. R. O. de Souza, I. d. M. Chaves, I. B. Passos, D. C. Teixeira, P. G. Bittencourt-Silva, P. A. C. Valadao, L. Rossi-Oliveira, M. M. Antunes, A. F. A. Figueiredo, , Costa

This study evaluates a murine model using MHV-3 to mimic COVID-19 pathogenesis and tests TNF inhibition as a therapeutic strategy.

bioRxiv · May 28, 2021 · PreprintMicrobiology